Akero Therapeutics Inc
(NAS:AKRO)
$
27.46
1.35 (5.17%)
Market Cap: 1.91 Bil
Enterprise Value: 1.18 Bil
PE Ratio: 0
PB Ratio: 2.38
GF Score: 43/100 Akero Therapeutics Inc (AKRO) Transcripts
- Akero Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Akero Therapeutics Inc Phase 2b SYMMETRY Data Presentation TranscriptOct 10, 2023
- Akero Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Akero Therapeutics Inc Phase 2b SYMMETRY Cohort D Data Presentation TranscriptJun 05, 2023
- Akero Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Akero Therapeutics Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 17, 2022
- Akero Therapeutics Inc Phase 2B HARMONY Trial Data Presentation TranscriptSep 13, 2022
- Akero Therapeutics Inc Annual Shareholders Meeting TranscriptJun 02, 2022
- Akero Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Akero Therapeutics Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Akero Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- 1